Загрузка...

🧪 Are we solving problems—or just publishing papers?

🧪 Are we solving problems—or just publishing papers?

After reading countless studies on Long COVID, I kept asking: Who’s actually trying to help people now?
Not 10 years from now. Not once a new humanized antibody is developed. Now.

So I stopped waiting for perfect answers—and started creating real ones.

As a scientist, I designed CircuGuard from the ground up: a safe, accessible supplement based on known mechanisms like microclot disruption. Not hypothetical. Not theoretical. Just built to help people feel human again.

Because the question shouldn’t be, “Is this publishable?”
It should be, “Does this help someone get out of bed tomorrow?”

----------

Subscribe to Keith’s Substack for recovery strategies backed by real science.

#CircuGuard #RealScienceRealSupport #ProgressStartsNow #ScienceBeforeSupplements #KeithEllisPhD #ScienceDrivenSupplements #Covid #Covid19 #Covid_19 #LongCovid #LongCovidAwareness #LongCovidRecovery #LongCovidSyndrome #LongCovidSymptoms #CovidClots #Microclots #TeamClots #MicroclotsConcerns #TripleAntiCoagulantTherapy #MedTikTok #RecoveringFromLongCovid #BrainFog #ChronicFatigue #ScienceBasedHealth #ScientificWellness #EvidenceBasedHealing

Видео 🧪 Are we solving problems—or just publishing papers? канала Keith C. Ellis, PhD | Long Covid Q&A
Страницу в закладки Мои закладки
Все заметки Новая заметка Страницу в заметки